Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide

The largest ever clinical trial in patients hospitalised with severe malaria has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults everywhere in the world. The study, funded by the Wellcome Trust, is published today online in the journal The Lancet.

Read the whole article on Physorg

More from Physorg